B cell responses to conjugate and polysaccharide meningococcal vaccines
<p>The primary approach to the control of meningococcal disease remains effective vaccination programmes in susceptible populations. Vaccines against serogroups A, C, W and Y offer broad protection against meningococci and both polysaccharide and conjugate quadrivalent vaccines are licensed fo...
Κύριος συγγραφέας: | Ramasamy, M |
---|---|
Άλλοι συγγραφείς: | Pollard, A |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2012
|
Θέματα: |
Παρόμοια τεκμήρια
-
Quadrivalent meningococcal conjugate vaccines
ανά: Pace, D, κ.ά.
Έκδοση: (2009) -
Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
ανά: Pollard, A, κ.ά.
Έκδοση: (2004) -
Global epidemiology of meningococcal disease and vaccine efficacy
ανά: Pollard, A
Έκδοση: (2004) -
Impact of serogroup A meningococcal conjugate vaccine for Africa
ανά: James M. Stuart
Έκδοση: (2018-05-01) -
Maintaining protection against invasive bacteria with protein - polysaccharide conjugate vaccines
ανά: Pollard, A, κ.ά.
Έκδοση: (2009)